135 related articles for article (PubMed ID: 36462492)
1. Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer.
Shen J; Xie M; Xu Y; Qian Q; Qiu T; Shi W; Ren D; Ji J; Huang J
Biochem Biophys Res Commun; 2023 Jan; 638():184-191. PubMed ID: 36462492
[TBL] [Abstract][Full Text] [Related]
2. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma.
Sun X; Cai M; Wu L; Zhen X; Chen Y; Peng J; Han S; Zhang P
Cancer Sci; 2022 Oct; 113(10):3463-3475. PubMed ID: 35880246
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells.
Wang J; Dong Y; Ma H; Wu L; Zhen X; Tang L; Jin J; Han S; Zhang P; Peng J
J Biol Chem; 2022 Jan; 298(1):101443. PubMed ID: 34822842
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer.
Diefenbacher ME; Popov N; Blake SM; Schülein-Völk C; Nye E; Spencer-Dene B; Jaenicke LA; Eilers M; Behrens A
J Clin Invest; 2014 Aug; 124(8):3407-18. PubMed ID: 24960159
[TBL] [Abstract][Full Text] [Related]
6. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage.
Jin C; Einig E; Xu W; Kollampally RB; Schlosser A; Flentje M; Popov N
Nucleic Acids Res; 2024 Apr; 52(6):3011-3030. PubMed ID: 38227944
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth.
Zhang L; Xu B; Qiang Y; Huang H; Wang C; Li D; Qian J
J Cell Mol Med; 2015 Apr; 19(4):799-805. PubMed ID: 25656529
[TBL] [Abstract][Full Text] [Related]
8. The USP18-FBXO6 axis maintains the malignancy of ovarian cancer.
Li G; Shi W; Xu Y; Li K; Chen Z; Lv M; Lv J; Qiu T; Qian Q; Ji J; Liu W; Liu B; Zhao Y
Biochem Biophys Res Commun; 2022 Feb; 593():101-107. PubMed ID: 35063764
[TBL] [Abstract][Full Text] [Related]
9. USP28 promotes aerobic glycolysis of colorectal cancer by increasing stability of FOXC1.
Liu Z; Chen M; Xu X; Zhang L; Pan Y; Chen D
Acta Biochim Pol; 2021 Jun; 68(4):633-639. PubMed ID: 34106567
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease.
Ren Y; Zhu X; Fu K; Zhang H; Zhao W; Lin Y; Fang Q; Wang J; Chen Y; Guo D
Biochem Pharmacol; 2023 Jan; 207():115355. PubMed ID: 36442624
[TBL] [Abstract][Full Text] [Related]
11. USP28 regulates deubiquitination of histone H2A and cell proliferation.
Li F; Han H; Sun Q; Liu K; Lin N; Xu C; Zhao Z; Zhao W
Exp Cell Res; 2019 Jun; 379(1):11-18. PubMed ID: 30910399
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28.
Toth RK; Solomon R; Warfel NA
Cells; 2022 Mar; 11(6):. PubMed ID: 35326457
[TBL] [Abstract][Full Text] [Related]
13. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
[TBL] [Abstract][Full Text] [Related]
14. FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development.
Ji J; Qian Q; Cheng W; Ye X; Jing A; Ma S; Ding Y; Ma X; Wang Y; Sun Q; Wang X; Chen Y; Zhu L; Yuan Q; Xu M; Qin J; Ma L; Yang J; Zhang M; Geng T; Wang S; Wang D; Song Y; Zhang B; Xu Y; Xu L; Liu S; Liu W; Liu B
Cell Death Dis; 2024 May; 15(5):332. PubMed ID: 38740744
[TBL] [Abstract][Full Text] [Related]
15. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
16. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.
Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C
Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243
[TBL] [Abstract][Full Text] [Related]
17. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity.
Gersch M; Wagstaff JL; Toms AV; Graves B; Freund SMV; Komander D
Mol Cell; 2019 May; 74(3):436-451.e7. PubMed ID: 30926242
[TBL] [Abstract][Full Text] [Related]
18. Targeting deubiquitinase USP28 for cancer therapy.
Wang X; Liu Z; Zhang L; Yang Z; Chen X; Luo J; Zhou Z; Mei X; Yu X; Shao Z; Feng Y; Fu S; Zhang Z; Wei D; Jia L; Ma J; Guo X
Cell Death Dis; 2018 Feb; 9(2):186. PubMed ID: 29415985
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells.
Wu Y; Wang Y; Yang XH; Kang T; Zhao Y; Wang C; Evers BM; Zhou BP
Cell Rep; 2013 Oct; 5(1):224-36. PubMed ID: 24075993
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of USP28 enhances the radiosensitivity of esophageal cancer cells via the c-Myc/hypoxia-inducible factor-1 alpha pathway.
Weili Z; Zhikun L; Jianmin W; Qingbao T
J Cell Biochem; 2019 Jan; 120(1):201-212. PubMed ID: 30206969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
